Showing results (1321-1330 of 1,729) with videos related to

Sort By:
Pageof 173
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.
Anesthesiology|February 6, 2014
Anesthesia-related cardiac arrestSheila J Ellis, Myrna C Newland, Jean A Simonson, et al.
Head & Neck|March 12, 2014
Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinomaJohn F Deeken, Kenneth Newkirk, K William Harter, et al.
Journal of Occupational and Environmental Medicine|August 21, 2024
Proceedings From a National Summit on Workplace Mental Health and Well-being: A Focus on the Graduate Academic EnvironmentEnid Chung Roemer, Ron Z Goetzel, Meghan F Davis, et al.
BMC Cancer|January 17, 2013
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumorsJoseph P Connor, Mihaela C Cristea, Nancy L Lewis, et al.
Oncotarget|May 31, 2018
Pericytes/vessel-associated mural cells (VAMCs) are the major source of key epithelial-mesenchymal transition (EMT) factors SLUG and TWIST in human gliomaLisa Mäder, Anna E Blank, David Capper, et al.
Gynecologic Oncology|May 24, 2024
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational statusClaudia Marchetti, Beyhan Ataseven, Anna M Perrone, et al.
Journal of Clinical Medicine|November 27, 2019
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsPia S Zeiner, Martina Kinzig, Iris Divé, et al.
Journal of the American Chemical Society|March 17, 2026
Molecular Dynamics-Guided Design and Chemoproteomic Profiling of Covalent Kinase Activity ProbesPratyasha Chakraborty, Anthony Carlos, Trayder Thomas, et al.
Neuro-Oncology|November 19, 2024
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessmentsKatharina J Müller, Robert Forbrig, Jonas Reis, et al.
Pageof 173